March 2020 Price Concessions – 1st Update

THIS CONTENT HAS NOW EXPIRED

March 2020 Price Concessions – 1st Update

March 13, 2020

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession
Amiodarone 200mg tablets 28 £2.35
Diclofenac sodium 100mg modified release tablets 28 £11.33
Frovatriptan 2.5mg tablets 6 £10.31
Hydroxyzine 10mg tablets 84 £2.09
Imipramine 25mg tablets 28 £3.79
Irbesartan 150mg tablets 28 £5.36
Irbesartan 300mg tablets 28 £4.70
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 £4.74
Lamotrigine 100mg dispersible tablets sugar free 56 £7.49
Lymecycline 408mg capsules 28 £6.45
Memantine 10mg tablets 28 £3.44
Memantine 20mg tablets 28 £8.88
Mirtazapine 15mg tablets 28 £2.29
Mirtazapine 30mg tablets 28 £1.89
Mirtazapine 45mg tablets 28 £2.74
Nefopam 30mg tablets 90 £10.10
Nitrofurantoin 50mg tablets 28 £12.45
Oxytetracycline 250mg tablets 28 £4.79
Quinine sulfate 300mg tablets 28 £6.67
Rivastigmine 3mg capsules 28 £3.97
Sulpiride 200mg tablets 30 £6.68
Tamoxifen 20mg tablets 30 £5.46
Trihexyphenidyl 2mg tablets 84 £9.42
Venlafaxine 37.5mg tablets 56 £6.50

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated March 2020 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

 



Posted in:


More Latest News >